Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Rome
Clinical trial register · Italy

Clinical Trials in Rome, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Italy and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 6778 matching records held by the registry are in this view. Synced 08 Oct 2026, 03:19 UTC
6778
Studies in scope
all four open statuses
4069
Recruiting now
open to new participants
1018
Lead sponsors
across recruiting studies
Top sites
Milan 18 Rome 17 Bologna 15 Rozzano 10 Naples 10
Narrow the registerReset
Recruitment status
Phase
Site location
Milan18 Rome17 Bologna15 Rozzano10 Naples10
All 44 locations
Target enrolment
to

Trials with a site in Rome

17 of 6778 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Italy
Start
Recruiting
Takeda
Phase 3
324
Bologna, Cona, Meldola, Rome, Milan, Ancona, Catania, Florence
2026-09-10
Active, closed
A Trial of TAK-861 for the Treatment of Narcolepsy With Cataplexy
NCT07363720Narcolepsy Type 1 (NT1), Narcolepsy With Cataplexy
Takeda
Phase 3
98
Bologna, Rome
2026-01-29
Recruiting
Takeda
Phase 3
110
Catania, Padova, Rome
2025-12-04
Recruiting
Takeda
Phase 2
200
Rozzano, Rome, Brescia, Florence
2025-11-03
Recruiting
Takeda
Phase 3
150
Naples, Rome, Catania, Bologna, Milan, Monza, Novara, Torino
2025-08-14
Recruiting
Takeda
Phase 2
88
Rome, Verona, Bologna
2025-05-06
Recruiting
Takeda
Phase 3
225
Ancona, Turin, Florence, Milan, Pavia, Reggio Calabria, Rome, Rozzano
2025-05-06
Recruiting
Takeda
Phase 3
1,088
Torrette, Rome, Milan, Rozzano, Padova, Florence, Pisa
2025-03-03
Recruiting
Takeda
Phase 3
171
Naples, Rome, Catania, Bologna, Milan, Monza, Novara, Torino
2025-02-27
Recruiting
Takeda
Phase 2
96
Pozzilli, Rome, Verona, Bologna
2025-02-07
Recruiting
Takeda
Phase 3
70
Messina, Milan, Pescara, Rome
2025-01-22
Recruiting
Takeda
Phase 3
30
Genova, Messina, Naples, Rome, Trieste
2024-11-19
Active, closed
Takeda
Phase 2
213
Bologna, Milan, Palermo, Rome, Rozzano
2024-03-29
Recruiting
Takeda
Phase 2
268
Bologna, Milan, Palermo, Roma, Rome, Rozzano
2024-03-05
Recruiting
Takeda
Phase 3
240
Naples, Bologna, Rome, Monza, Florence, Padova
2023-05-16
Recruiting
Takeda
Phase 2/3
500
Rome, Pozzilli, Bellaria
2023-04-05
Recruiting
Takeda
Phase 3
120
Naples, Bologna, Rome, Monza, Padova
2022-02-10
Rows per page Showing 1–17 of 17
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Italian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 11 October 2026. https://priyalifescience.com/clinical-trials-italy/city/rome

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Italy and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,778 studies in total at the last sync on 08 Oct 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 17 of those studies with a site in Rome that also match the filters currently applied.

How many clinical trials are recruiting in Rome?

15 of the 17 studies on this page are recruiting new participants as of the 08 Oct 2026, 03:19 UTC sync. A further 0 have not yet opened recruitment, 2 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Rome), 17 studies
PhaseStudiesRecruitingShare
Phase 3111064.7%
Phase 25429.4%
Phase 2/3115.9%

Most active sponsors

Lead sponsors with the most studies (Rome)
Lead sponsorStudiesRecruiting
Takeda1715
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.